A Blueprint Medicines Corp. patent describes new cyclin-dependent kinase 2 (CDK2) inhibitors reported to be useful for the treatment of cancer.

Title: INX-315, an oral, potent and selective CDK2 inhibitor in patients with CDK4/6 inhibitor resistant ER+/HER2- breast cancer or CCNE1 amplified solid tumors: phase 1 monotherapy dose escalation ...

A powerful three-drug combination for aggressive advanced breast cancer doubles the length of time before the cancer progresses, compared with a drug combination currently available on the NHS, new ...

Disease progression in metastatic breast cancer is a challenge that no single entity can solve alone. Breakthroughs in ...

Presented clinical data for multiple assets across modalities, including bispecific antibody candidate BNT327/PM8002 and mRNA cancer vaccine ...

David Sacks/ Getty Images Can you claim a dependent on your tax return? If so, there are federal tax breaks, such as the earned income tax credit (EITC) and the child tax credit (CTC), that can ...

as both the Pentagon and NASA have become deeply dependent on Musk’s company SpaceX for space launches and satellite internet. Responding to Vox’s request for comment, SpaceX’s media ...